New USFDA warning letters show Glenmark, Lupin, Cadila Healthcare in trouble Medical Dialogues Bureau7 Nov 2019 4:20 PM ISTCadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd. and Lupin Ltd. are the latest local medicine makers to be reprimanded by the US Food and Drug...
Aurobindo Pharma gets 8 USFDA observations for 2 facilities in Hyderabad Medical Dialogues Bureau7 Nov 2019 9:45 AM ISTThe USFDA inspected active pharmaceutical ingredients (API) manufacturing facility (Unit V) at Pashamylaram and API manufacturing facility (Unit VIII)...
Novartis arm wins USFDA nod for biosimilar Ziextenzo in oncology care Medical Dialogues Bureau7 Nov 2019 9:30 AM ISTNew Delhi: Novartis division, Sandoz recently announced that the US Food and Drug Administration (USFDA) approved its biosimilar ZiextenzoTM...
Lupin posts Rs 123 crore net loss in Q2 Medical Dialogues Bureau7 Nov 2019 9:15 AM ISTLupin said it has agreed to pay Rs 450.06 crore as settlement in connection with the lawsuit in the US and, accordingly, a provision of Rs 379.18...
OxyContin maker Purdue Pharma gets interim shield from litigation Medical Dialogues Bureau7 Nov 2019 9:00 AM ISTU.S. Bankruptcy Judge Robert Drain said on Wednesday he would approve an order extending a stay on more than 2,600 lawsuits that accuse Purdue Pharma...
Zydus Cadila gets USFDA nod for generic muscle relaxing Cisatracurium Besylate Injection Medical Dialogues Bureau6 Nov 2019 1:30 PM ISTNew Delhi: Cadila Healthcare on Tuesday said group firm Zydus Cadila has received final approval from the US health regulator for its generic version...
Sun Pharma signs licensing pact with AstraZeneca to introduce Novel Oncology products in China Medical Dialogues Bureau6 Nov 2019 1:26 PM ISTMumbai-Indian drugmaker giant Sun Pharma announced today about entering into an agreement with AstraZeneca to enter the Chinese market with novel...
Novartis gets U.S. nod for long-delayed copycat version of Amgen billion seller Neulasta drug Medical Dialogues Bureau6 Nov 2019 10:32 AM ISTZURICH: Novartis on Tuesday won U.S. approval for its long-delayed version of Amgen's $4 billion seller Neulasta drug, helping the Swiss drugmaker in...
Japan's Takeda to sell portfolio of select drugs for USD 660 million Medical Dialogues Bureau6 Nov 2019 9:19 AM ISTTakeda Pharmaceutical Co Ltd, Japan's largest drugmaker, said on Tuesday it would sell some of its over-the-counter and prescription drugs to...
Biocon gets EIR from USFDA for Bengaluru biologics unit Medical Dialogues Bureau6 Nov 2019 9:19 AM ISTNew Delhi: Biopharmaceutical firm Biocon on Tuesday said it has received an establishment inspection report (EIR) from the US health regulator for its...
Zydus Cadila receives warning letter from USFDA for Moraiya-based formulation facility Medical Dialogues Bureau5 Nov 2019 12:57 PM ISTNew Delhi: Drug firm Zydus Cadila on Monday said it has received a warning letter from the US health regulator for its Moraiya-based formulation...
Medical device maker Stryker to buy Wright Medical for USD 4 Billion Medical Dialogues Bureau5 Nov 2019 12:56 PM ISTMedical device maker Stryker Corp said on Monday it would buy smaller rival Wright Medical Group for about $4 billion in cash.The deal for $30.75 per...
